PubMed COVID-19 Clinical Care

Cutaneous reactions following immunization, while rare, are a known adverse effect of many vaccinations. The precise etiology of such dermatologic manifestations and their long-term effects are largely unknown. This case study describes a 37-year-old

CONCLUSIONS: This is the only case of phantosmia reported after the use of the J&J COVID-19 vaccine and aligns with the literature that reports 1 case of phantosmia and 2 cases of hyposmia following the Pfizer-BioNTech COVID-19 mRNA vaccine. This

CONCLUSION: The COVID-19 pandemic disrupted and impacted older adults' well-being worldwide. Despite the cultural and socio-economic differences many commonalities were found. Studies described the impact of mass media reporting, social connectivity

CONCLUSIONS: Maternal and perinatal survival was negatively affected in referral hospitals in sub-Saharan Africa during COVID-19. Routine data systems in referral hospitals must be fully used as they hold potential in informing adaptations of

Objective: Understanding the discernment of individuals about their health is crucial during public health situations such as the COVID-19 pandemic. Within this theme of study is how older adults perceive their vulnerabilities because it can relate

CONCLUSIONS: In this sample, no patient tested had a detectable methanol concentration. Children who consumed enough to have a detectable ethanol concentration were symptomatic or had an intentional ingestion. Asymptomatic children with unintentional

CONCLUSION: The 320 kcal (30% fat) GES scintigraphic test provides consistent diagnosis in >85% and should be the standard test for suspected gastric emptying disorders.

DESCRIPTION: Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP) living, rapid practice points focusing on 22 outpatient

CONCLUSION: Nirmatrelvir-ritonavir and molnupiravir probably improve outcomes for outpatients with mild to moderate COVID-19.

No abstract